WASHINGTON, DC - The Subcommittee on Health, chaired by Rep. Joseph Pitts (R-PA), announced a hearing for Tuesday, Sept. 27, 2016, at 10 a.m. in room 2322 of the Rayburn House Office Building. The hearing is entitled, “Examining Expanded Access to Investigational Therapies."
The subcommittee will examine the complicated web of issues related to biopharmaceutical companies producing and providing patients with access to investigational drug compounds that are in various stages of development and have yet to be fully reviewed or approved by the FDA. The subcommittee will discuss the processes currently in place and potential room for improvement.
“Next week’s fact-finding hearing will help grow our understanding of current policy surrounding patient access to drug compounds still in development," said Chairman Pitts. “We will continue to look for ways to help patients and their providers navigate this often complicated process involving FDA, bioethicists, and pharmaceutical companies."
The Majority Memorandum, a witness list, and witness testimony will be available here as they are posted.
